Chiltern International Limited, often referred to simply as Chiltern, is a prominent global contract research organisation (CRO) headquartered in Great Britain. Established in 1982, the company has made significant strides in the clinical research industry, providing comprehensive services across various therapeutic areas, including oncology, cardiology, and neurology. With a strong presence in Europe, North America, and Asia, Chiltern offers a unique blend of expertise in clinical trial management, regulatory affairs, and data management. Their commitment to innovation and quality has positioned them as a trusted partner for pharmaceutical and biotechnology companies seeking to navigate the complexities of drug development. Notable achievements include successful collaborations with leading industry players, underscoring their reputation as a key player in the global clinical research landscape.
How does Chiltern International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Chiltern International Limited's score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chiltern International Limited, headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Labcorp Holdings Inc., which means that any climate commitments or emissions data may be inherited from this parent organization. Chiltern International Limited has not outlined specific reduction targets or initiatives in its own right. However, it is important to note that the climate commitments and performance metrics may be influenced by Labcorp Holdings Inc., which operates under various sustainability initiatives, including those aligned with the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). As a subsidiary, Chiltern's climate strategy may reflect the broader goals set by Labcorp, although specific details regarding these targets or achievements have not been disclosed. The absence of direct emissions data and reduction targets indicates a potential area for improvement in transparency and accountability regarding their environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 864,000 |
| Scope 2 | 7,424,000 |
| Scope 3 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Chiltern International Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.